Tag: T cell
Phase II Trial Finds Chinese COVID-19 Vaccine is Safe, Induces Immune Response
BEIJING: A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has.
BEIJING: A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has.